National Heart, Lung, and Blood Institute
Catalyze Product Definition: Medical Device Prototype and Assay Development (R61/R33)
Deadline
December 23, 2027
Eligibility
United States, Foreign components allowed
Funding Amount
Unlock to view
Grant Overview
Catalyze Product Definition: Medical Device Prototype and Assay Development (R61/R33) is a research funding opportunity offered by National Heart, Lung, and Blood Institute covering areas such as Medical Devices, Diagnostics, Assay Development, Biomedical Engineering for applicants in United States, Foreign components allowed. The application deadline is December 23, 2027.
Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.
Focus Areas
Geographic Eligibility
- •United States
- •Foreign components allowed
Before You Apply
Confirm the final deadline, applicant requirements, funding conditions and submission instructions on the official funder website before submitting an application.